Sanofi (SNY) Tops Q1 EPS by EUR0.10

Sanofi (NASDAQ: SNY) reported Q1 EPS of EUR1.42, EUR0.10 better than the analyst estimate of EUR1.32. Revenue for the quarter came in at EUR8.39 billion versus the consensus estimate of EUR8.32 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sanofi (SNY) call put ratio 8.4 calls to 1 put with a focus on July 45 calls